Showing results (371-380 of 498) with videos related to
Sort By:
Pageof 50
Journal for Immunotherapy of Cancer|April 21, 2016
Disease stabilization with pembrolizumab for metastatic acral melanoma in the setting of autoimmune bullous pemphigoidKristen M Beck, Joanna Dong, Larisa J Geskin, et al.Journal of the American College of Cardiology|September 1, 1988
The reversal of amiodarone-induced perioperative reduction in cardiac systolic reserve in dogsW D Spotnitz, S P Nolan, D L Kaiser, et al.Archives of Otolaryngology--Head & Neck Surgery|November 17, 2004
Serum cotinine level and incident hearing loss: a case-control studyDavid M Nondahl, Karen J Cruickshanks, Dayna S Dalton, et al.Cancer|February 1, 1995
A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group studyW S Dalton, J J Crowley, S S Salmon, et al.Noise & Health|September 14, 2007
The use of hearing protection devices by older adults during recreational noise exposureD M Nondahl, K J Cruickshanks, D S Dalton, et al.Scientific Data|November 5, 2024
An in-air synthetic aperture sonar dataset of target scattering in environments of varying complexityThomas E Blanford, David P Williams, J Daniel Park, et al.Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|December 4, 2023
Long term survival following a medical emergency team call at an Australian regional hospitalNathan S Dalton, Rebecca J Kippen, Michael J Leach, et al.Journal of the American Academy of Dermatology|April 19, 2011
A randomized controlled trial of oral phosphate binders in the treatment of pseudoxanthoma elasticumJane Y Yoo, Robin R Blum, Giselle K Singer, et al.European Journal of Clinical Nutrition|April 9, 2009
Long-term effects of increased dietary polyunsaturated fat from walnuts on metabolic parameters in type II diabetesL C Tapsell, M J Batterham, G Teuss, et al.Leukemia|October 10, 2008
Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosisT Lwin, L A Crespo, A Wu, et al.Pageof 50